Home Top Movers Is Check Cap Ltd (CHEK) Stock a buy now?

Is Check Cap Ltd (CHEK) Stock a buy now?

Things have started to change for Check Cap since the NASDAQ compliance re-gain extension. 

The clinical-stage medical diagnostics company shares are trading with strong momentum. The average trading volume of Check-Cap Ltd. (CHEK) is just over 8 million. As we write this on Jan 5., the trading volume is almost 235 million. Is it a good time to jump in and buy the stock?


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


What going on?

Check-Cap Ltd. (CHEK) stock is skyrocketing, but what’s the exact reason? On Dec. 30, 2020, the company received a notice of a 180-day extension to regain NASDAQ compliance. This allows the stocks to have enough time to trade above the $1 minimum required share price on the market. 

This NASDAQ compliance extension has driven high volume over the past week. Investors are now seeing things in a positive way as the company tries to fight back.

Back in Nov. 2020, the company announced that it had submitted the Investigational Device Exemption (IDE) application to the FDS for its pivotal study of C-Scan. The IDE is a great achievement towards the initiation of the pivotal study in the U.S. The company is expected to provide updates on its C-Scan study in the near future, following the guidance from the FDA. 

Moreover, the company is preparing well at the backend for the U.S. pivotal study; improving the supply chain, quality controls, and device manufacturing. The company is also managing the expansion of this study at the leading Israeli sites. 

The core objective of Check-Cap is to advance its C-Scan towards the final cynical stages and make it to the market. The C-Scan is being developed as a patient-friendly colorectal cancer (CRC) screening option—detecting pre-cancerous polyps. The company expects a response from the FDA anytime soon.

However, on the other side of the picture, there are concerns regarding Check-Cap’s cash balance. As of Sep. 2020, the company had cash of $21 million with zero debt. Essentially, the cash burn was almost $13 million over the past twelve months. With that, the company had only 19 months of cash runway. The worrying part is that if the company runs out of cash, and that too in the middle of a pandemic. 

Check-cap is still in its early days and is developing as a business. The increase in cash burn shows that the company is focused on future growth and its current focus on its C-Scan pivotal study. 

Conclusion

Wall Street is positive on Check-Cap Ltd. (CHEK) and expects medical diagnostics to grow in the long-term. The game will change once the company receives the guidance update from the FDA on IDE. However, analysts’ rate CHEK stock as a strong buy. The average price target is around $1.7, with an upside of 32% over the next 12 months.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

What Is Getting Alteryx (AYX) Stock To Soar In Premarket Trades?

The shares of Alteryx Inc. (AYX) rose 7.42% to trade at $82.06 in premarket trading at last check. To close Tuesday's trading session at...

Cocrystal Pharma, Inc. (COCP) Stock Skyrocketed Following Promising Updates on Covid-19 Drug Development

Cocrystal Pharma, Inc. (COCP) stock prices were up by a monumental 72.58% as of the market closing on may 4th 2021, bringing the price...

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) stock slumped in the afterhours trading session; here’s why

At last check, in the after-hours trading session, ADMP stock had slumped by-7.48% to $0.99. ADMP stock previously closed the session at $1.07 gaining...

Here is why iBio Inc (IBIO) stock rallied in the after-hours on Tuesday?

iBio Inc. (IBIO) shares gained 31.01% to trade at $1.69 in the after-market on Tuesday, May 4, 2021. Earlier IBIO's stock lost 4.44% to...

10x Genomics (NASDAQ: TXG) stock slumped in the premarket trading session; here’s why

10x Genomics Inc. (TXG) stock plunged by-9.79% to the price of $165.0 in pre-market trading session. TXG stock has closed previous session at $182.90...

My Size Inc. (NASDAQ: MYSZ) stock plunged during after-hour trading, given no latest update

My Size Inc. (NASDAQ: MYSZ) stock surged by 24.87% at last close whereas the MYSZ stock price declined by 4.13% in the after hours...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Related News

10x Genomics (NASDAQ: TXG) stock slumped in the premarket trading session; here’s why

10x Genomics Inc. (TXG) stock plunged by-9.79% to the price of $165.0 in pre-market trading session. TXG stock has closed previous session at $182.90...

Yellow Corporation (NASDAQ:YELL) stock has plunged in the aftermarket trading session; find out why

At last check, in the afterhours trading session, Yellow Corporation (YELL) stock plunged by-14.23% to the price of $8.2. YELL stock closed previous session...

What is behind the rise of Applied Genetic Technologies Corporation(AGTC) stock in the after-market?

Applied Genetic Technologies Corporation (Nasdaq: AGTC) a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for treatment of...

How Come The Aldeyra (ALDX) Stock Has Been Rising In Pre-Market Trades?

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) rose 6.59% to trade at $12.78 per share at last check-in premarket trading. During Tuesday's session, Aldeyra stock fell...

Shares of Aurora Mobile Limited (JG) were inclining in premarket? Why did it happen?

Aurora Mobile Limited (NASDAQ: JG) a leading big data solutions platform in China, saw stock price rising immensely as Oppenheimer analyst Bo Pei initiated...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.